NATASHA ANDREWS: Open Payments
NPI 1548556947 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 13 payments from 8 companies in 2025. Trend: 2023 $325 · 2024 $909 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $325 |
| Alkermes, Inc. | 3 | $173 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $78 |
| Axsome Therapeutics, Inc. | 1 | $71 |
| Phathom Pharmaceuticals, Inc. | 1 | $36 |
| Lundbeck LLC | 2 | $29 |
Products named: REPATHA, LYBALVI, NUZYRA, Epclusa, AIRSUPRA, Auvelity, VOQUEZNA, REXULTI.
Industry payments across AL — which companies pay providers there.
